Toll like receptor 2 agonists lipoteichoic acid and peptidoglycan are able to enhance antigen specific IFNγ release in whole blood during recall antigen responses

Journal of Immunological Methods

Volumn 396, Issue 1-2, 2013, Pages 107-115

  Dammermann, Werner ^a   Wollenberg, Lisa ^a   Bentzien, Frank ^a   Lohse, Ansgar ^a   Lüth, Stefan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Agonist; Interferon gamma release assay; Lipoteichoic acid; Peptidoglycan; Toll like receptor

Indexed keywords

ANTIGEN; BROPIRIMINE; FLAGELLIN; GAMMA INTERFERON; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; LOXORIBINE; PEPTIDOGLYCAN; POLYINOSINIC POLYCYTIDYLIC ACID; RESIQUIMOD; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; ZYMOSAN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BLOOD; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; INTERFERON GAMMA RELEASE ASSAY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AGONIST; INTERFERON GAMMA RELEASE ASSAY; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR;

ADULT; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MALE; PEPTIDOGLYCAN; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2;

EID: 84884322238     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.08.004     Document Type: Article

References (27)

1. Aguero-Rosenfeld M.E., Wang G., Schwartz I., Wormser G.P. Diagnosis of lyme borreliosis. Clin. Microbiol. Rev. 2005, 18:484.
2. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499.
3. Arias M.A., Van Roey G.A., Tregoning J.S., Moutaftsi M., Coler R.N., Windish H.P., Reed S.G., Carter D., Shattock R.J. Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140. PLoS One 2012, 7:e41144.
4. Burdash N., Fernandes J. Lyme borreliosis: detecting the great imitator. J. Am. Osteopath. Assoc. 1991, 91:573.
5. Caron G., Duluc D., Fremaux I., Jeannin P., David C., Gascan H., Delneste Y. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J. Immunol. 2005, 175:1551.
6. Chakera A., Bennett S.C., Cornall R.J. A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response. J. Transl. Med. 2011, 9:143.
7. Chen X.Z., Mao X.H., Zhu K.J., Jin N., Ye J., Cen J.P., Zhou Q., Cheng H. Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells. Arch. Dermatol. Res. 2010, 302:57.
8. Clari M.A., Munoz-Cobo B., Solano C., Benet I., Costa E., Remigia M.J., Bravo D., Amat P., Navarro D. Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients. Clin. Vaccine Immunol. 2012, 19:791.
9. Cooper C., Mackie D. Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV safety and efficacy. Expert Rev. Vaccines 2011, 10:417.
10. Drew P.D., Franzoso G., Becker K.G., Bours V., Carlson L.M., Siebenlist U., Ozato K. NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J. Interferon Cytokine Res. 1995, 15:1037.
11. Gaur R.L., Suhosk M.M., Banaei N. In vitro immunomodulation of a whole blood IFN-gamma release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS One 2012, 7:e48027.
12. Ghosh S., Hayden M.S. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 2008, 8:837.
13. Goossens H.A., Nohlmans M.K., van den Bogaard A.E. Epstein-Barr virus and cytomegalovirus infections cause false-positive results in IgM two-test protocol for early Lyme borreliosis. Infection 1999, 27:231.
14. Halperin S.A., Ward B.J., Dionne M., Langley J.M., McNeil S.A., Smith B., Mackinnon-Cameron D., Heyward W.L., Martin J.T. Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine. Hum. Vaccin. Immunother. 2013, 9.
15. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987.
16. Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 2007, 19:39.
17. Komai-Koma M., Jones L., Ogg G.S., Xu D., Liew F.Y. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3029.
18. Lalvani A., Pareek M. Interferon gamma release assays: principles and practice. Enferm. Infecc. Microbiol. Clin. 2009, 28(4):245.
19. Lee K.W., Lee Y., Kim D.S., Kwon H.J. Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression. Eur. J. Immunol. 2006, 36:1254.
20. Marques A., Brown M.R., Fleisher T.A. Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls. Clin. Vaccine Immunol. 2009, 16:1249.
21. Ruhwald M., Petersen J., Kofoed K., Nakaoka H., Cuevas L.E., Lawson L., Squire S.B., Eugen-Olsen J., Ravn P. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 2008, 3:e2858.
22. Smyth K., Garcia K., Sun Z., Tuo W., Xiao Z. TLR agonists are highly effective at eliciting functional memory CTLs of effector memory phenotype in peptide immunization. Int. Immunopharmacol. 2012, 15(1):67.
23. Steere A.C., McHugh G., Damle N., Sikand V.K. Prospective study of serologic tests for lyme disease. Clin. Infect. Dis. 2008, 47:188.
24. Streeton J.A., Desem N., Jones S.L. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int. J. Tuberc. Lung Dis. 1998, 2:443.
25. Stricker R.B., Winger E.E. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol. Lett. 2001, 76:43.
26. Vacchelli E., Galluzzi L., Eggermont A., Fridman W.H., Galon J., Sautes-Fridman C., Tartour E., Zitvogel L., Kroemer G. Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. Oncoimmunology 2012, 1:894.
27. von Baehr V., Doebis C., Volk H.D., von B.R. The lymphocyte transformation test for borrelia detects active lyme borreliosis and verifies effective antibiotic treatment. Open. Neurol. J. 2012, 6:104.